Doximity Crecimiento futuro
Future controles de criterios 2/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Doximity de 9.7% y 9.8% por año respectivamente. Se prevé que el BPA crezca en un 11.9% al año. Se espera que la rentabilidad financiera sea de 16.9% en 3 años.
Información clave
9.7%
Tasa de crecimiento de los beneficios
11.9%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Healthcare Services | 27.5% |
| Tasa de crecimiento de los ingresos | 9.8% |
| Rentabilidad financiera futura | 16.9% |
| Cobertura de analistas | Good |
| Última actualización | 25 Apr 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Doximity: Significant Upside Remains, But Not Until The Growth Story Returns
Apr 29With Doximity, Inc. (NYSE:DOCS) It Looks Like You'll Get What You Pay For
Apr 16
Estimating The Fair Value Of Doximity, Inc. (NYSE:DOCS)
Mar 26Doximity: Rating Upgrade To Buy As Outlook Turns Positive
Feb 21We Like Doximity's (NYSE:DOCS) Earnings For More Than Just Statutory Profit
Feb 15What Is Doximity, Inc.'s (NYSE:DOCS) Share Price Doing?
Feb 13Doximity: Downside Is Contained, While Upside Depends On Management's Game Plan
Jan 16Doximity (NYSE:DOCS) May Have Issues Allocating Its Capital
Jan 04Doximity, Inc.'s (NYSE:DOCS) Intrinsic Value Is Potentially 29% Above Its Share Price
Dec 14Doximity Earnings: Steer Clear Of This Rollercoaster War Of Optimism Vs. Skepticism
Nov 10Doximity: Adding Value Using AI But Faces Near-Term Risks
Nov 01Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?
Oct 30Doximity (NYSE:DOCS) Might Be Having Difficulty Using Its Capital Effectively
Sep 25Doximity: Rating Downgrade As Investors Shift Focus To The Near-Term Outlook
Aug 24Doximity Earnings: Too Many Problems, Sell
Aug 09A Look At The Intrinsic Value Of Doximity, Inc. (NYSE:DOCS)
Jul 29Why Doximity, Inc. (NYSE:DOCS) Could Be Worth Watching
Jul 09Doximity: Continue To See Positive Upside From Current Stock Level
Jul 05The Returns At Doximity (NYSE:DOCS) Aren't Growing
Jun 21Doximity: Digital Health Play With Strong Fundamentals
Jun 21A Look At The Fair Value Of Doximity, Inc. (NYSE:DOCS)
Apr 07Doximity (NYSE:DOCS) Is Reinvesting At Lower Rates Of Return
Mar 20Doximity: Good Business But Extremely Overvalued
Feb 18Doximity Q3 Earnings: Disappointing Results
Feb 10Calculating The Fair Value Of Doximity, Inc. (NYSE:DOCS)
Dec 25Doximity: On The Right Path To Further Consolidate Market Share
Dec 22Here's What's Concerning About Doximity's (NYSE:DOCS) Returns On Capital
Dec 04Doximity up 16% after fiscal 2023 Q2 beats, FY revenue range includes consensus
Nov 10Doximity, down 9%, falls below IPO price
Oct 12Doximity Appears Well-Positioned But Shares May Be Fully Valued Here
Aug 11Doximity Non-GAAP EPS of $0.14 beats by $0.03, revenue of $90.6M beats by $0.95M
Aug 04Unpleasant Surprises Could Be In Store For Doximity, Inc.'s (NYSE:DOCS) Shares
Jul 09Pair Trade: Going Long Doximity And Short Teladoc
Jul 05Doximity: Slowing Guidance, Stock Drops, But It Oozes Cash Flows
May 18Doximity: Turning Bullish After Stock Price Correction
Apr 01Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 3/31/2027 | 634 | 182 | 232 | 240 | 5 |
| 3/31/2026 | 575 | 162 | 224 | 234 | 13 |
| 3/31/2025 | 520 | 145 | 200 | 204 | 17 |
| 3/31/2024 | 474 | 137 | 181 | 190 | 17 |
| 12/31/2023 | 468 | 138 | 162 | 167 | N/A |
| 9/30/2023 | 448 | 123 | 160 | 165 | N/A |
| 6/30/2023 | 437 | 119 | 186 | 192 | N/A |
| 3/31/2023 | 419 | 113 | 173 | 180 | N/A |
| 12/31/2022 | 402 | 119 | 173 | 180 | N/A |
| 9/30/2022 | 384 | 141 | 151 | 159 | N/A |
| 6/30/2022 | 362 | 148 | 131 | 138 | N/A |
| 3/31/2022 | 344 | 133 | 121 | 127 | N/A |
| 12/31/2021 | 317 | 107 | 113 | 117 | N/A |
| 9/30/2021 | 277 | 57 | 110 | 114 | N/A |
| 6/30/2021 | 243 | 30 | 103 | 107 | N/A |
| 3/31/2021 | 207 | 22 | 78 | 83 | N/A |
| 12/31/2020 | 177 | 14 | 48 | 53 | N/A |
| 3/31/2020 | 116 | 11 | 22 | 26 | N/A |
| 3/31/2019 | 86 | 1 | 14 | 15 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (9.7% al año) de DOCS es superior a la tasa de ahorro (2.3%).
Beneficios vs. Mercado: Se prevé que los beneficios (9.7% al año) de DOCS crezcan menos que el mercado US (14.6% al año).
Beneficios de alto crecimiento: Se prevé que los beneficios de DOCS crezcan, pero no significativamente.
Ingresos vs. Mercado: Se prevé que los ingresos (9.8% al año) de DOCS crezcan más rápidamente que los del mercado US (8% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 9.8% al año) de DOCS crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de DOCS sea baja dentro de 3 años (16.9%).